BioSpace News Archive

Hyloris Pharmaceuticals SA, a specialty biopharma company committed to addressing unmet medical needs through reinventing existing medications, announces it has out-licensed its product candidate atomoxetine oral liquid for the treatment of attention deficit hyperactivity disorder in Canada to Kye Pharmaceuticals.

This week at CPHI Barcelona, Pharmatech Associates will showcase its expertise and capabilities that help global pharmaceutical and emerging biotech companies accelerate their innovation and speed delivery of breakthrough medicines and therapies to patients.

Sandoz, the global leader in generic and biosimilar medicines, announced its year-to-date sales for the first nine months of 2023, with net sales up 6 percent in constant currencies to reach USD 7.1 billion.

Sangamo Therapeutics, Inc., a genomic medicine company, announced that the European Society of Gene & Cell Therapy has accepted six Sangamo abstracts for presentation at the 30th Annual Congress being held October 24-27, 2023, in-person in Brussels, Belgium.

Spago Nanomedical AB announces the publication of four new patent applications filed with the European Patent Office to expand and extend the patent protection for the company’s radionuclide therapy Tumorad.

Science 37 Holdings, Inc., the industry-leading Metasite™ announced it will report third quarter 2023 financial results prior to the market open on Tuesday, November 7, 2023.

Centene Corporation announced its financial results for the third quarter ended September 30, 2023.

Elektrofi, Inc. announced that it has entered a multi-target research collaboration and license agreement with Eli Lilly and Company to develop next-generation medicines that can be delivered subcutaneously.

Ocean Biomedical, Inc., announced that its Chief Scientist, Jonathan Kurtis MD, PhD has received the prestigious Falk Medical Research Trust Transformational Award to advance a new class of anti-malarial drug candidates.

KalVista Pharmaceuticals, Inc. announced the presentation of a novel analysis characterizing hereditary angioedema attacks occurring in patients receiving long-term prophylaxis treatments at the Asia Pacific Association of Allergy, Asthma and Clinical Immunology 2023 International Conference in Singapore.